Angela A. Armstrong

Array ( [id] => 5508507 [patent_doc_number] => 20090081714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Assays' [patent_app_type] => utility [patent_app_number] => 11/988456 [patent_app_country] => US [patent_app_date] => 2006-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6859 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081714.pdf [firstpage_image] =>[orig_patent_app_number] => 11988456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219222 [patent_doc_number] => 20070160533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Pharmacokinetic modulation and compositions for modified Fn3 polypeptides' [patent_app_type] => utility [patent_app_number] => 11/482641 [patent_app_country] => US [patent_app_date] => 2006-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 40271 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20070160533.pdf [firstpage_image] =>[orig_patent_app_number] => 11482641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662099 [patent_doc_number] => 20060252695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Analysis and separation of platelet-derived growth factor proteins' [patent_app_type] => utility [patent_app_number] => 11/483033 [patent_app_country] => US [patent_app_date] => 2006-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9835 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252695.pdf [firstpage_image] =>[orig_patent_app_number] => 11483033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759903 [patent_doc_number] => 20080312129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Use of Mas G-Protein-Coupled Receptor Agonists and Antagonists, as Apoptotic-Activity Modulators for Study, Prevention and Treatment of Diseases' [patent_app_type] => utility [patent_app_number] => 11/922949 [patent_app_country] => US [patent_app_date] => 2006-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6646 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312129.pdf [firstpage_image] =>[orig_patent_app_number] => 11922949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477521 [patent_doc_number] => 20100041596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Amelioration of Inflammatory Arthritis By Targeting the Pre-ligand Assembly Domain (Plad) of Tumor Necrosis Factor Receptors' [patent_app_type] => utility [patent_app_number] => 11/922547 [patent_app_country] => US [patent_app_date] => 2006-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 31547 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041596.pdf [firstpage_image] =>[orig_patent_app_number] => 11922547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5050922 [patent_doc_number] => 20070031467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'COMPOSITION AND METHOD FOR VASCULAR EMBOLIZATION' [patent_app_type] => utility [patent_app_number] => 11/425280 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11411 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031467.pdf [firstpage_image] =>[orig_patent_app_number] => 11425280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154329 [patent_doc_number] => 20070037212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Human T2R receptors recognizing a class of bitter molecules from coffee' [patent_app_type] => utility [patent_app_number] => 11/455693 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18598 [patent_no_of_claims] => 128 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037212.pdf [firstpage_image] =>[orig_patent_app_number] => 11455693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5050923 [patent_doc_number] => 20070031468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Modified chitosan for vascular embolization' [patent_app_type] => utility [patent_app_number] => 11/447794 [patent_app_country] => US [patent_app_date] => 2006-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6330 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031468.pdf [firstpage_image] =>[orig_patent_app_number] => 11447794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5022160 [patent_doc_number] => 20070148126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Inhibitors of type 2 vascular endothelial growth factor receptors' [patent_app_type] => utility [patent_app_number] => 11/448171 [patent_app_country] => US [patent_app_date] => 2006-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 40465 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20070148126.pdf [firstpage_image] =>[orig_patent_app_number] => 11448171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5193516 [patent_doc_number] => 20070082000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'D1-1 nucleic acids, polypeptides and related methods' [patent_app_type] => utility [patent_app_number] => 11/437755 [patent_app_country] => US [patent_app_date] => 2006-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30524 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082000.pdf [firstpage_image] =>[orig_patent_app_number] => 11437755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786437 [patent_doc_number] => 20060205660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'OB protein-immunoglobulin chimeras' [patent_app_type] => utility [patent_app_number] => 11/433186 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 12586 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205660.pdf [firstpage_image] =>[orig_patent_app_number] => 11433186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5360461 [patent_doc_number] => 20090035255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'CONJUGATE FOR TARGETING OF DRUG' [patent_app_type] => utility [patent_app_number] => 11/913483 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10037 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035255.pdf [firstpage_image] =>[orig_patent_app_number] => 11913483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720076 [patent_doc_number] => 20080242599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Compositions and Methods for Increasing Osteoblast Cell Differentiation and Bone Generation' [patent_app_type] => utility [patent_app_number] => 11/913643 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20463 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 48 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242599.pdf [firstpage_image] =>[orig_patent_app_number] => 11913643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5704812 [patent_doc_number] => 20060193860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Treatment of schizophrenia' [patent_app_type] => utility [patent_app_number] => 11/415719 [patent_app_country] => US [patent_app_date] => 2006-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23927 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20060193860.pdf [firstpage_image] =>[orig_patent_app_number] => 11415719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5224635 [patent_doc_number] => 20070253901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Atherosclerosis genes and related reagents and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/412437 [patent_app_country] => US [patent_app_date] => 2006-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 67732 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20070253901.pdf [firstpage_image] =>[orig_patent_app_number] => 11412437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5302885 [patent_doc_number] => 20090297537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level' [patent_app_type] => utility [patent_app_number] => 11/919381 [patent_app_country] => US [patent_app_date] => 2006-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 35627 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297537.pdf [firstpage_image] =>[orig_patent_app_number] => 11919381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337857 [patent_doc_number] => 20090054321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Polypeptides and use thereof' [patent_app_type] => utility [patent_app_number] => 11/918642 [patent_app_country] => US [patent_app_date] => 2006-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11126 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054321.pdf [firstpage_image] =>[orig_patent_app_number] => 11918642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564613 [patent_doc_number] => 20090137466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Use of GLP-1, Exendin and Agonists Thereof To Delay or Prevent Cardiac Remodeling' [patent_app_type] => utility [patent_app_number] => 11/910730 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14263 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137466.pdf [firstpage_image] =>[orig_patent_app_number] => 11910730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4988653 [patent_doc_number] => 20070154992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants' [patent_app_type] => utility [patent_app_number] => 11/402105 [patent_app_country] => US [patent_app_date] => 2006-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 48649 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154992.pdf [firstpage_image] =>[orig_patent_app_number] => 11402105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10155788 [patent_doc_number] => 09187546 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants' [patent_app_type] => utility [patent_app_number] => 11/910958 [patent_app_country] => US [patent_app_date] => 2006-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 50 [patent_no_of_words] => 49238 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910958 [rel_patent_id] =>[rel_patent_doc_number] =>)